Carson was appointed Chief Financial Officer on February 1, 2026. Ms. Carson was previously appointed Vice President Finance and Administration and entered into an offer letter and employment agreement, effective May 12, 2025, pursuant to which she was entitled to an initial annual base salary of $290,000 and was eligible to receive an annual bonus of up to 30% of her annual base salary, based on the achievement of c

filing / Aug 14, 2026 / receipt

Carson was previously appointed Vice President Finance and Administration and entered into an offer letter and employment agreement, effective May 12, 2025, pursuant to which she was entitled to an initial annual base salary of $290,000 and was eligible to receive an annual bonus of up to 30% of her annual base salary, based on the achievement of certain performance goals established annually by the Board.

filing / Aug 14, 2026 / receipt

Former director Robert Ferrera resigned from the Board on October 31, 2025.

filing / Aug 14, 2026 / receipt

Robert J. Bitterman 75 President, Chief Executive Officer and Chair of the Board of Directors

filing / Aug 14, 2026 / receipt

Lisa Carson 60 Chief Financial Officer

filing / Aug 14, 2026 / receipt

Robert J. Bitterman has served as a member and the Chair of the Board since 2012

filing / Aug 14, 2026 / receipt

The Company currently maintains shared office space at LifeSciences PA located at 411 Swedeland Road, King of Prussia, PA for access to full working space during normal business hours of operations for a monthly fee of $ 300 .

filing / Aug 6, 2026 / receipt